Apellis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. T…
Biotechnology
US, Waltham [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Apellis Pharmaceuticals, Inc.

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
- -% Yield
0.00% Payout Ratio
End of APLS's Analysis
CIK: 1492422 CUSIP: 03753U106 ISIN: US03753U1060 LEI: - UEI: -
Secondary Listings
APLS has no secondary listings inside our databases.